Skip to content
10-Q

Quarterly Report

REGENERON PHARMACEUTICALS, INC. REGN

0000872589-25-000019

← back to feed
Filed
Aug 1, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2025 · Jun 30, 2025 108.6M sh
Shares Diluted Q2 2025 · Jun 30, 2025 109.9M sh
Shares Diluted Q2 2025 · Jun 30, 2024 115.4M sh
Shares Diluted Q2 2025 · Jun 30, 2024 115.3M sh
Stock Repurchased Q2 2025 · Jun 30, 2025 $2.1B
Stock Repurchased Q2 2025 · Jun 30, 2024 $895.2M
Dividends Paid Q2 2025 · Jun 30, 2025 $186.4M
Dividends Paid Q2 2025 · Jun 30, 2024 $0
Capex Q2 2025 · Jun 30, 2025 $448.3M
Capex Q2 2025 · Jun 30, 2024 $314.4M
Operating Cash Flow Q2 2025 · Jun 30, 2025 $2.19B
Operating Cash Flow Q2 2025 · Jun 30, 2024 $1.87B
Long Term Debt Q2 2025 · Jun 30, 2025 $1.99B
Long Term Debt Q2 2025 · Dec 31, 2024 $1.98B
Cash And Equivalents Q2 2025 · Jun 30, 2025 $2B
Cash And Equivalents Q2 2025 · Dec 31, 2024 $2.49B
Cash And Equivalents Q2 2025 · Jun 30, 2024 $1.92B
Stockholders Equity Q2 2025 · Jun 30, 2025 $29.94B
Stockholders Equity Q2 2025 · Mar 31, 2025 $29.39B
Stockholders Equity Q2 2025 · Dec 31, 2024 $29.35B
Stockholders Equity Q2 2025 · Jun 30, 2024 $28.21B
Stockholders Equity Q2 2025 · Mar 31, 2024 $26.99B
Stockholders Equity Q2 2025 · Dec 31, 2023 $25.97B
Current Liabilities Q2 2025 · Jun 30, 2025 $3.67B
Current Liabilities Q2 2025 · Dec 31, 2024 $3.94B
Total Liabilities Q2 2025 · Jun 30, 2025 $8.28B
Total Liabilities Q2 2025 · Dec 31, 2024 $8.41B
Current Assets Q2 2025 · Jun 30, 2025 $16.86B
Current Assets Q2 2025 · Dec 31, 2024 $18.66B
Total Assets Q2 2025 · Jun 30, 2025 $38.22B
Total Assets Q2 2025 · Dec 31, 2024 $37.76B
Eps Diluted Q2 2025 · Jun 30, 2025 $12.81
Eps Diluted Q2 2025 · Jun 30, 2025 $20.02
Eps Diluted Q2 2025 · Jun 30, 2024 $12.41
Eps Diluted Q2 2025 · Jun 30, 2024 $18.68
Eps Basic Q2 2025 · Jun 30, 2025 $13.24
Eps Basic Q2 2025 · Jun 30, 2025 $20.78
Eps Basic Q2 2025 · Jun 30, 2024 $13.25
Eps Basic Q2 2025 · Jun 30, 2024 $19.95
Sga Expense Q2 2025 · Jun 30, 2025 $634.2M
Sga Expense Q2 2025 · Jun 30, 2025 $1.27B
Sga Expense Q2 2025 · Jun 30, 2024 $758.8M
Sga Expense Q2 2025 · Jun 30, 2024 $1.45B
Rd Expense Q2 2025 · Jun 30, 2025 $1.42B
Rd Expense Q2 2025 · Jun 30, 2025 $2.75B
Rd Expense Q2 2025 · Jun 30, 2024 $1.2B
Rd Expense Q2 2025 · Jun 30, 2024 $2.45B
Net Income Q2 2025 · Jun 30, 2025 $1.39B
Net Income Q2 2025 · Jun 30, 2025 $2.2B
Net Income Q2 2025 · Mar 31, 2025 $808.7M
Net Income Q2 2025 · Jun 30, 2024 $1.43B
Net Income Q2 2025 · Jun 30, 2024 $2.15B
Net Income Q2 2025 · Mar 31, 2024 $722M
Operating Income Q2 2025 · Jun 30, 2025 $1.08B
Operating Income Q2 2025 · Jun 30, 2025 $1.67B
Operating Income Q2 2025 · Jun 30, 2024 $1.07B
Operating Income Q2 2025 · Jun 30, 2024 $1.82B
Revenue Q2 2025 · Jun 30, 2025 $3.68B
Revenue Q2 2025 · Jun 30, 2025 $6.7B
Revenue Q2 2025 · Jun 30, 2024 $3.55B
Revenue Q2 2025 · Jun 30, 2024 $6.69B